Outset Medical PE Ratio 2019-2025 | OM

Current and historical p/e ratio for Outset Medical (OM) from 2019 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Outset Medical PE ratio as of June 20, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Outset Medical PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-06-20 18.98 0.00
2025-03-31 11.06 $-29.15 0.00
2024-12-31 16.65 $-37.18 0.00
2024-09-30 10.16 $-41.38 0.00
2024-06-30 57.75 $-47.08 0.00
2024-03-31 33.30 $-50.67 0.00
2023-12-31 81.15 $-52.47 0.00
2023-09-30 163.20 $-53.82 0.00
2023-06-30 328.05 $-52.62 0.00
2023-03-31 276.00 $-52.92 0.00
2022-12-31 387.30 $-51.13 0.00
2022-09-30 238.95 $-51.27 0.00
2022-06-30 222.90 $-48.28 0.00
2022-03-31 681.00 $-44.38 0.00
2021-12-31 691.35 $-43.18 0.00
2021-09-30 741.60 $-41.38 0.00
2021-06-30 749.70 $-83.21 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.336B $0.114B
Outset Medical Inc. is a medical technology company. Its Tablo(R) Hemodialysis System represents technological advancement enabling novel, transformational dialysis care in acute and home settings. Outset Medical Inc. is based in CA, United States.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.768B 58.23
Hims & Hers Health (HIMS) United States $14.374B 149.35
Tempus AI (TEM) United States $11.826B 0.00
IRhythm Technologies (IRTC) United States $4.653B 0.00
Inspire Medical Systems (INSP) United States $3.861B 60.33
Hinge Health (HNGE) United States $3.282B 0.00
Privia Health (PRVA) United States $2.664B 182.08
Enovis (ENOV) United States $1.720B 9.59
Phreesia (PHR) United States $1.560B 0.00
Clover Health Investments (CLOV) United States $1.537B 0.00
Schrodinger (SDGR) United States $1.501B 0.00
Azenta (AZTA) United States $1.357B 63.06
10x Genomics (TXG) United States $1.331B 0.00
Omnicell (OMCL) United States $1.313B 23.17
Claritev (CTEV) United States $0.657B 0.00
Fulgent Genetics (FLGT) United States $0.595B 0.00
Butterfly Network (BFLY) United States $0.514B 0.00
Veradigm (MDRX) United States $0.487B 0.00
Talkspace (TALK) United States $0.448B 134.00
Standard BioTools (LAB) United States $0.399B 0.00
TruBridge (TBRG) United States $0.337B 746.67
Nyxoah SA (NYXH) Belgium $0.263B 0.00
Health Catalyst (HCAT) United States $0.251B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.156B 0.00
EUDA Health Holdings (EUDA) Singapore $0.138B 0.00
CareCloud (CCLD) United States $0.106B 4.03
Pulmonx (LUNG) United States $0.105B 0.00
American Well (AMWL) United States $0.105B 0.00
MDxHealth SA (MDXH) Belgium $0.094B 0.00
111 (YI) China $0.069B 0.00
HeartBeam (BEAT) United States $0.051B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.046B 0.00
P3 Health Partners (PIII) United States $0.045B 0.00
Zhongchao (ZCMD) China $0.037B 0.00
Zepp Health (ZEPP) Netherlands $0.035B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.010B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.001B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00